Frontlight ResearchEarly access
Trial site
Kyushu Cancer Center
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Gastric and oesophageal cancer2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Head and neck cancer1 trial
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- ALX Oncology Inc.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Australasian Gastro-Intestinal Trials Group1 trial
- Daiichi Sankyo1 trial
- Hutchison Medipharma Limited1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Recruiting
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
Active, not recruiting
A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026